๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Gland Pharma Limited (BOM:543245)
India flag India ยท Delayed Price ยท Currency is INR
3,331.35
+40.30 (1.22%)
At close: Nov 20, 2026

Gland Pharma Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
70,72064,30756,16556,64736,24644,007
Revenue Growth
21.90%14.50%-0.85%56.28%-17.64%27.08%
Gross Profit
41,99437,97231,54431,10817,65121,513
Operating Income
14,63511,9068,7219,7158,84414,000
Net Income
12,35910,2736,9857,7257,81012,117
Earnings Per Share
74.8862.2842.4046.8947.4373.64
EPS Growth
56.07%46.89%-9.58%-1.14%-35.59%16.91%

Revenue by Geography

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
USA
37,06831,18527,40326,87820,91023,327
Europe
15,62414,11010,22510,5281,8712,398
India
5,3055,5104,7655,8805,5488,801
Rest of World (ROW)
10,68411,16911,37711,8176,8938,481
Canada
-1,4041,574890.27794.9829.19
Australia
-851.32742.94626.45218.24170.87
New Zealand
-77.1177.2328.1710.86-
Total
70,72164,30756,16556,64736,24644,007

Cash & Debt

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
34,41233,59129,52219,38837,62832,457
Total Debt
2,5122,8363,1373,72244.5347.43
Net Cash (Debt)
31,90030,75526,38515,66637,58432,410
Net Cash Growth
10.01%16.56%68.42%-58.32%15.96%8.10%
Net Cash Per Share
193.29186.45160.1595.10228.22196.97

Cash Flow & CapEx

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
10,40910,3149,1479,9683,6407,908
Capital Expenditures
-5,510-4,908-3,845-3,899-2,209-5,113
Free Cash Flow
4,8995,4065,3026,0691,4302,794
Free Cash Flow Growth
10.59%1.97%-12.63%324.27%-48.81%-25.71%

Margins

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
59.38%59.05%56.16%54.92%48.70%48.88%
Operating Margin
20.69%18.52%15.53%17.15%24.40%31.81%
Pretax Margin
24.52%22.77%18.92%19.99%29.10%36.78%
Profit Margin
17.47%15.97%12.44%13.64%21.55%27.53%
FCF Margin
6.93%8.41%9.44%10.71%3.95%6.35%

Dividends

Fiscal Year
CurrentFY 2026FY 2025FY 2024
Period EndingNov '26 Mar '26 Mar '25 Mar '24
Dividend Per Share
20.00020.00018.00020.000
Dividend Per Share Growth
11.11%11.11%-10.00%-
Dividend Yield
0.60%1.18%1.13%1.08%

Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
44.4927.2037.5639.3526.7444.38
P/FCF Ratio
112.2051.6949.4850.08146.03192.42
PS Ratio
7.774.354.675.375.7612.22